Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Kuros Biosciences AG CSBTF

Set alert

Price alert · CSBTF

All alert types
23.00 USD 0.00 0.00%

At close · Oct 30

24.00 Day range 24.00
22.00 52-week range 38.91
YTD
-40.01%
1 year
-36.46%
Open
24.00
Prev close
23.00
Mkt cap
914.40M
Vol
1.00K
Avg vol
61
EPS
0.22
P/E
104.55
More statistics
Low
24.00
High
24.00

MAX chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The all-time price history for CSBTF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

11.01 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 1
  • Return on Equity 3
  • Return on Assets 4
  • Debt / Equity 3
  • P/E 1
  • P/B 1

Valuation

P/E 552×
FY 2016: -7.8×FY 2017: -12.7×FY 2018: -2.3×FY 2019: -0.5×FY 2020: -4.5×FY 2021: -10.1×FY 2022: -4.1×FY 2023: -8.5×FY 2024: -205×FY 2025: 552×
FY 2016 5y median -8.5× FY 2025
P/S 9.6×
FY 2016: 145×FY 2017: 391×FY 2018: 37.6×FY 2019: 2.3×FY 2020: 12.8×FY 2021: 5.5×FY 2022: 3.3×FY 2023: 3.5×FY 2024: 10.1×FY 2025: 9.6×
FY 2016 5y median 5.5× FY 2025
P/B 17.5×
FY 2016: 4.0×FY 2017: 2.9×FY 2018: 0.4×FY 2019: 0.1×FY 2020: 0.6×FY 2021: 1.0×FY 2022: 0.9×FY 2023: 2.1×FY 2024: 13.0×FY 2025: 17.5×
FY 2016 5y median 2.1× FY 2025
P/FCF -486×
FY 2016: -17.2×FY 2017: -17.0×FY 2018: -2.0×FY 2019: -0.5×FY 2020: -5.5×FY 2021: -13.1×FY 2022: -7.8×FY 2023: -12.9×FY 2024: 376×FY 2025: -486×
FY 2016 5y median -12.9× FY 2025
EV/EBITDA 115×
FY 2016: -7.3×FY 2017: -12.7×FY 2018: -0.7×FY 2019: 1.5×FY 2020: -3.0×FY 2021: -9.4×FY 2022: -5.5×FY 2023: -16.0×FY 2024: -1331×FY 2025: 115×
FY 2016 5y median -9.4× FY 2025
EV/Sales 9.5×
FY 2016: 133×FY 2017: 360×FY 2018: 12.0×FY 2019: -4.9×FY 2020: 6.3×FY 2021: 3.6×FY 2022: 2.1×FY 2023: 3.2×FY 2024: 9.9×FY 2025: 9.5×
FY 2016 5y median 3.6× FY 2025
FCF Yield -0.2%
FY 2016: -5.8%FY 2017: -5.9%FY 2018: -50.2%FY 2019: -187.7%FY 2020: -18.3%FY 2021: -7.6%FY 2022: -12.9%FY 2023: -7.7%FY 2024: 0.3%FY 2025: -0.2%
FY 2016 5y median -7.6% FY 2025

Profitability

Gross Margin 86.4%
FY 2016: -272.5%FY 2017: -518.9%FY 2018: -377.8%FY 2019: -3.1%FY 2020: 41.4%FY 2021: 72.9%FY 2022: 59.9%FY 2023: 84.8%FY 2024: 82.1%FY 2025: 86.4%
FY 2016 5y median 82.1% FY 2025
Operating Margin 6.0%
FY 2016: -2011.9%FY 2017: -3041.8%FY 2018: -1919.9%FY 2019: -444.8%FY 2020: -289.2%FY 2021: -63.5%FY 2022: -74.8%FY 2023: -39.3%FY 2024: -6.6%FY 2025: 6.0%
FY 2016 5y median -39.3% FY 2025
Net Margin 1.7%
FY 2016: -1860.9%FY 2017: -3086.9%FY 2018: -1635.4%FY 2019: -439.4%FY 2020: -285.2%FY 2021: -54.6%FY 2022: -81.1%FY 2023: -40.9%FY 2024: -4.9%FY 2025: 1.7%
FY 2016 5y median -40.9% FY 2025
ROE 3.2%
FY 2016: -51.5%FY 2017: -22.5%FY 2018: -15.3%FY 2019: -14.5%FY 2020: -13.6%FY 2021: -9.8%FY 2022: -21.2%FY 2023: -24.2%FY 2024: -6.3%FY 2025: 3.2%
FY 2016 5y median -9.8% FY 2025
ROIC 5.5%
FY 2016: -51.3%FY 2017: -19.8%FY 2018: -14.2%FY 2019: -12.8%FY 2020: -12.3%FY 2021: -8.6%FY 2022: -17.3%FY 2023: -22.4%FY 2024: -7.8%FY 2025: 5.5%
FY 2016 5y median -8.6% FY 2025
ROA 2.0%
FY 2016: -45.1%FY 2017: -19.1%FY 2018: -13.6%FY 2019: -12.8%FY 2020: -12.2%FY 2021: -8.3%FY 2022: -17.6%FY 2023: -19.2%FY 2024: -4.4%FY 2025: 2.0%
FY 2016 5y median -8.3% FY 2025

Growth (YoY)

Revenue 60.6%
FY 2016: -83.3%FY 2017: -49.7%FY 2018: 33.9%FY 2019: 258.2%FY 2020: 57.7%FY 2021: 242.0%FY 2022: 30.2%FY 2023: 86.6%FY 2024: 125.1%FY 2025: 60.6%
FY 2016 FY 2025
Operating Income 246.8%
FY 2016: -3363.9%FY 2017: 23.9%FY 2018: 15.5%FY 2019: 17.0%FY 2020: -2.5%FY 2021: 24.9%FY 2022: -53.4%FY 2023: 1.9%FY 2024: 62.1%FY 2025: 246.8%
FY 2016 FY 2025
EPS (diluted) 151.3%
FY 2016: -181.4%FY 2017: 41.1%FY 2018: 39.4%FY 2019: 42.1%FY 2020: 28.8%FY 2021: 51.1%FY 2022: -87.0%FY 2023: 11.6%FY 2024: 73.7%FY 2025: 151.3%
FY 2016 FY 2025
Free Cash Flow -218.6%
FY 2016: -255.7%FY 2017: -37.0%FY 2018: -10.2%FY 2019: 18.8%FY 2020: 13.8%FY 2021: 38.4%FY 2022: -33.0%FY 2023: -18.4%FY 2024: 122.1%FY 2025: -218.6%
FY 2016 FY 2025

Financial Health

Current Ratio 1.6×
FY 2016: 4.1×FY 2017: 3.8×FY 2018: 4.9×FY 2019: 6.4×FY 2020: 8.8×FY 2021: 2.9×FY 2022: 2.5×FY 2023: 2.1×FY 2024: 2.1×FY 2025: 1.6×
FY 2016 5y median 2.1× FY 2025
Quick Ratio 1.2×
FY 2016: 4.0×FY 2017: 3.7×FY 2018: 4.8×FY 2019: 6.1×FY 2020: 8.4×FY 2021: 2.8×FY 2022: 2.2×FY 2023: 1.7×FY 2024: 1.7×FY 2025: 1.2×
FY 2016 5y median 1.7× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -1.4×
FY 2016: 0.6×FY 2017: 1.1×FY 2018: 1.6×FY 2019: 2.2×FY 2020: 3.0×FY 2021: 5.0×FY 2022: 3.2×FY 2023: 1.8×FY 2024: 27.9×FY 2025: -1.4×
FY 2016 5y median 3.2× FY 2025
Interest Coverage 24.0×
FY 2016: -147×FY 2017: -41.3×FY 2018: -109×FY 2019: -17.5×FY 2020: -13.8×FY 2021: -6.3×FY 2022: -3.1×FY 2023: 7.6×FY 2024: -33.5×FY 2025: 24.0×
FY 2016 5y median -3.1× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31